Compare Ginkgo Bioworks Holdings Inc (DNA) vs The Coca-Cola Co K (KO) Price & Performance

Ginkgo Bioworks (DNA) trades at $7.42, down 3.01% with bearish technical signals. The company reported Q2 2026 revenue of $20M, down 48% year-over-year, while maintaining a high gross margin of 68.04% but significant net losses. Analyst sentiment is mixed with 45% buy ratings amid ongoing business model transition to autonomous laboratory systems and contract research services.

The outlook remains challenging with persistent revenue declines and negative cash flow, though recent earnings beats provide some optimism. Key risks include execution of the business pivot and path to profitability. Wall Street shows cautious optimism with majority buy ratings despite fundamental headwinds.

Coca-Cola (KO) trades at $86.67, down 0.23% on the day, with a bullish technical signal driven by moving averages and strong support at $85. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $0.97 exceeding expectations, and maintains high profitability margins, including a 28.56% net income margin. Recent news highlights institutional buying and stable demand trends, while the upcoming Q3 2026 earnings are anticipated at $0.87 EPS.

The stock offers a compelling dividend yield with 64 consecutive years of increases, supported by solid cash flow and a consensus price target of $95.83 implying 10.6% upside. Risks include regional demand volatility in Asia and high debt levels, but analyst sentiment is bullish with 60% buy ratings. Long-term growth prospects remain intact given brand strength and global footprint.